Literature DB >> 17437129

Focal and segmental glomerulosclerosis in children: a longitudinal assessment.

Olivia Boyer1, Janelle K Moulder, Michael J G Somers.   

Abstract

Recent data suggest that the histologic finding of focal and segmental glomerulosclerosis (FSGS) is increasing among children. There are, however, limited longitudinal pediatric data on prevalence, demographics, and steroid responsiveness in FSGS. We identified 201 consecutive nephrotic children diagnosed between 1977 and 2002 with 2 years follow-up; 51% had undergone renal biopsy due to steroid sequelae or resistance; 48 children with FSGS were diagnosed. Compared with non-FSGS children, FSGS children were older at diagnosis (6.9 years vs 4.4 years, P<0.02), more likely girls (54% vs 28%, P<0.02), Black or Hispanic (42% vs 16%, P<0.001), and the FSGS was more likely to be steroid resistant (73% vs 10%, P<0.001). To assess for longitudinal differences, we grouped children by presentation: pre-1985, between 1985 and 1995, and post-1995. There was no difference in proportion of children biopsied or diagnosed with FSGS during each interval. Among FSGS children, there was no difference in racial or gender composition in each period, but there was a difference in age at diagnosis (2.6 vs 5.7 vs 8.5 years; P=0.01), also observed in the non-FSGS children (2.2 vs 3.9 vs 4.9 years; P=0.02). In contradistinction to non-FSGS children, there was a marked increase in steroid resistance with FSGS (43% vs 62% vs 86%; P=0.03).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437129     DOI: 10.1007/s00467-007-0493-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  24 in total

1.  Treatment of primary focal segmental glomerulosclerosis.

Authors:  Stephen M Korbet
Journal:  Kidney Int       Date:  2002-12       Impact factor: 10.612

2.  Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis.

Authors:  Marcelo M Abrantes; Luis Sergio B Cardoso; Eleonora M Lima; José M Penido Silva; José S Diniz; Eduardo A Bambirra; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

3.  Changing patterns in the histopathology of idiopathic nephrotic syndrome in children.

Authors:  M Bonilla-Felix; C Parra; T Dajani; M Ferris; R D Swinford; R J Portman; R Verani
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

4.  Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?

Authors:  C Ponticelli; M Villa; G Banfi; B Cesana; C Pozzi; A Pani; P Passerini; M Farina; C Grassi; A Baroli
Journal:  Am J Kidney Dis       Date:  1999-10       Impact factor: 8.860

5.  Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children.

Authors:  J Churg; R Habib; R H White
Journal:  Lancet       Date:  1970-06-20       Impact factor: 79.321

Review 6.  Is there really an increase in non-minimal change nephrotic syndrome in children?

Authors:  Guido Filler; Elizabeth Young; Pavel Geier; Blair Carpenter; Alfred Drukker; Janusz Feber
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

7.  Urinary tract diseases revealed after DTP vaccination in infants and young children: cytokine irregularities and down-regulation of cytochrome P-450 enzymes induced by the vaccine may uncover latent diseases in genetically predisposed subjects.

Authors:  Joseph Prandota
Journal:  Am J Ther       Date:  2004 Sep-Oct       Impact factor: 2.688

8.  Age and ethnicity affect the risk and outcome of focal segmental glomerulosclerosis.

Authors:  J M Sorof; E P Hawkins; E D Brewer; I I Boydstun; A S Kale; D R Powell
Journal:  Pediatr Nephrol       Date:  1998-11       Impact factor: 3.714

Review 9.  Hypothesis: dysregulation of immunologic balance resulting from hygiene and socioeconomic factors may influence the epidemiology and cause of glomerulonephritis worldwide.

Authors:  Richard J Johnson; Abdias Hurtado; Justin Merszei; Bernardo Rodriguez-Iturbe; Lili Feng
Journal:  Am J Kidney Dis       Date:  2003-09       Impact factor: 8.860

10.  Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study.

Authors:  M Haas; B H Spargo; S Coventry
Journal:  Am J Kidney Dis       Date:  1995-11       Impact factor: 8.860

View more
  19 in total

Review 1.  Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptor.

Authors:  Hernán Trimarchi
Journal:  World J Nephrol       Date:  2013-11-06

2.  Increasing frequency of acute kidney injury amongst children hospitalized with nephrotic syndrome.

Authors:  Michelle N Rheault; Chang-Ching Wei; David S Hains; Wei Wang; Bryce A Kerlin; William E Smoyer
Journal:  Pediatr Nephrol       Date:  2013-09-14       Impact factor: 3.714

3.  Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

Authors:  J Bradley Layton; Susan L Hogan; Caroline E Jennette; Barbara Kenderes; Jenna Krisher; J Charles Jennette; William M McClellan
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

4.  Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life.

Authors:  Debbie S Gipson; Howard Trachtman; Frederick J Kaskel; Milena K Radeva; Jennifer Gassman; Tom H Greene; Marva M Moxey-Mims; Ronald J Hogg; Sandra L Watkins; Richard N Fine; John P Middleton; V M Vehaskari; Susan L Hogan; Suzzane Vento; Patti A Flynn; Leslie M Powell; June L McMahan; Norman Siegel; Aaron L Friedman
Journal:  Kidney Int       Date:  2010-12-22       Impact factor: 10.612

5.  Risk profiles of progression in primary focal segmental glomerulosclerosis.

Authors:  Lori L Travis; James C M Chan
Journal:  World J Pediatr       Date:  2010-08-13       Impact factor: 2.764

6.  Discovery and initial validation of α 1-B glycoprotein fragmentation as a differential urinary biomarker in pediatric steroid-resistant nephrotic syndrome.

Authors:  Nuntawan Piyaphanee; Qing Ma; Oran Kremen; Kimberly Czech; Kenneth Greis; Mark Mitsnefes; Prasad Devarajan; Michael R Bennett
Journal:  Proteomics Clin Appl       Date:  2011-05-18       Impact factor: 3.494

7.  Efficacy of intravenous pulse cyclophosphamide treatment versus combination of intravenous dexamethasone and oral cyclophosphamide treatment in steroid-resistant nephrotic syndrome.

Authors:  Mukta Mantan; Chenni S Sriram; Pankaj Hari; Amit Dinda; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2008-06-20       Impact factor: 3.714

8.  Expression of JAKs/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis.

Authors:  Yaojun Liang; Yu Jin; Yuning Li
Journal:  Pediatr Nephrol       Date:  2009-04-07       Impact factor: 3.714

9.  Racial and ethnic differences in pediatric access to preemptive kidney transplantation in the United States.

Authors:  R E Patzer; B A Sayed; N Kutner; W M McClellan; S Amaral
Journal:  Am J Transplant       Date:  2013-06-03       Impact factor: 8.086

10.  Circulating suPAR in two cohorts of primary FSGS.

Authors:  Changli Wei; Howard Trachtman; Jing Li; Chuanhui Dong; Aaron L Friedman; Jennifer J Gassman; June L McMahan; Milena Radeva; Karsten M Heil; Agnes Trautmann; Ali Anarat; Sevinc Emre; Gian M Ghiggeri; Fatih Ozaltin; Dieter Haffner; Debbie S Gipson; Frederick Kaskel; Dagmar-Christiane Fischer; Franz Schaefer; Jochen Reiser
Journal:  J Am Soc Nephrol       Date:  2012-11-08       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.